entertainment -WSS

entertainment

author：entertainment 2025-09-09 03:32:08 - browse：31916

The Food and Drug Administration’s advisory panel of pediatric experts met on Tuesday to discuss advances in artificial womb technology, which aim to save the lives of premature babies.

The goal of the meeting was to discuss measures for evaluating the safety and efficacy of an artificial womb. The group grappled with the limits of current animal data, as well as the ethical difficulties in running human trials. On Wednesday, the committee’s meeting will be closed to the public in order to protect trade secrets.

Extremely premature babies, defined as infants born at less than 28 weeks, rarely survive. About half of infants born at 23 weeks survive, according to a 2022 study in the Journal of the American Medical Association, and at 22 weeks just 10% survive. This population represents less than 2% of all premature babies, but the problem is growing; the Centers for Disease Control and Prevention reported that the preterm birth rate rose by 4% between 2020 and 2021.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Nobel honors Karikó and Weissman's enduring partnership

hotspot

WSS

How to bring more disabled researchers into academia

Change Healthcare payments predicted restored March 15

What we owe ALS patients — and why one company fell short

Will an HIV vaccine ever be a reality?

What we owe ALS patients — and why one company fell short

Flu, Covid vaccination rates decline, new survey data show

Wikipedia

entertainment

Wikipedia

23andMe had bad news about my health. I wish a person had delivered it

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Apple is now the first public company to be valued at $3 trillion

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Walensky prepares to leave CDC — and Congress — behind

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Trump demands the U.S. pay no more for drugs than other countries … again

Change Healthcare payments predicted restored March 15

Trump demands the U.S. pay no more for drugs than other countries … again

With psoriasis trial ahead, Alumis raises $259 million

leisure time

Stop Congress from blocking public access to science

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Will an HIV vaccine ever be a reality?

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

IVG is promising — but it won’t replace IVF quite yet

Medicare innovation center doesn’t save money, experts say

hotspot

hotspot

Wikipedia

focus